NDC 62064-122-02
TROGARZO 150 mg/mL
ibalizumab · INJECTION, SOLUTION
TROGARZO is a injection, solution containing ibalizumab at a strength of 150 mg/mL. Manufactured by Theratechnologies Inc..
Key Facts
- Brand Name
- TROGARZO
- Generic Name
- ibalizumab
- NDC Code (Package)
62064-122-02- NDC Code (Product)
62064-122- Manufacturer
- Theratechnologies Inc.
- Strength
- 150 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761065
- Drug Class
- CD4-directed Blocking Antibody [EPC]; Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]
- Marketing Start
- 04/20/2018
Recall History
No Recall HistoryView Full Drug Page
TROGARZO — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.